| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.049 | 0.3 |